Boston Scientific Corporation
Clinical trials sponsored by Boston Scientific Corporation, explained in plain language.
-
New heart device tested in 500 chinese patients: will it tame irregular heartbeats?
Disease control Recruiting nowThis study tracks 500 Chinese patients with paroxysmal atrial fibrillation who are treated with the FARAPULSE pulsed field ablation system as part of their normal care. Researchers will monitor safety and effectiveness for up to three years. The goal is to see how well the device…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 01, 2026 22:00 UTC
-
New heart mapping technique could improve ablation for persistent AF
Disease control Recruiting nowThis global trial compares two ablation strategies for people with persistent atrial fibrillation (AF) that hasn't responded to medication. One group gets standard ablation of the pulmonary veins and back wall of the left atrium. The other group gets ablation guided by a special …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 01, 2026 22:00 UTC
-
New heart ablation waveforms aim to tame atrial fibrillation
Disease control Recruiting nowThis study tests new waveforms delivered by the FARAPULSE PFA system to treat atrial fibrillation, a common heart rhythm problem. About 200 adults with paroxysmal or persistent atrial fibrillation will receive the procedure. The goal is to see if these new waveforms are safe and …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 01, 2026 22:00 UTC
-
One-Stop shop: new study tests dual procedure for AFib patients
Disease control Recruiting nowThis study is testing whether it is safe and effective to perform two heart procedures at the same time in people with atrial fibrillation (AF). The first procedure uses pulsed field ablation to correct the heart's rhythm, and the second closes off a small pouch in the heart to r…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 01, 2026 22:00 UTC
-
Stomach balloon aims to help obese patients shed pounds safely
Disease control Recruiting nowThis study tests a temporary stomach balloon called Orbera365 to help people with obesity lose weight. About 144 adults with a BMI between 28 and 50 who have not succeeded with diet and exercise will get the balloon. The main goal is to see if at least 5% of body weight is lost a…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 01, 2026 22:00 UTC
-
New heart device aims to tame stubborn AFib
Disease control Recruiting nowThis study is testing the FARAPULSE Pulsed Field Ablation system in 376 people with persistent atrial fibrillation (AFib) who have already had a prior ablation. The device uses electrical pulses to destroy the heart tissue causing the abnormal rhythm. The goal is to see if it is …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 01, 2026 22:00 UTC
-
New heart zapping device could free patients from irregular heartbeat
Disease control Recruiting nowThis study tests a new device called FARAFLEX that uses electrical pulses to treat atrial fibrillation (AF), a condition where the heart beats irregularly. About 571 adults with AF that hasn't improved with medication will get this procedure. The goal is to see if it safely resto…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New heart device aims to zap away irregular rhythm
Disease control Recruiting nowThis study is testing a new device called the FARAFLEX system, which uses targeted electrical pulses to treat atrial fibrillation, a common heart rhythm problem. About 250 adults with persistent or paroxysmal atrial fibrillation will take part. The goal is to see if the device is…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New heart implant aims to cut stroke risk without blood thinners
Disease control Recruiting nowThis study is tracking 1000 people with atrial fibrillation who receive the WATCHMAN FLX Pro device, a small implant that closes off a part of the heart to prevent blood clots from causing strokes. The goal is to see how safe and effective the device is in everyday medical practi…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Stomach balloon study aims to help people with obesity shed pounds safely
Disease control Recruiting nowThis study tracks 200 adults with obesity in the EU who choose to get the Orbera365 intragastric balloon. The balloon is placed in the stomach and filled with saline to help people feel full and eat less. Researchers will monitor serious side effects and how much weight participa…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Double whammy for AFib: single procedure aims to fix rhythm and prevent strokes
Disease control Recruiting nowThis study tests doing two heart procedures at the same time for people with atrial fibrillation. First, doctors use pulsed field energy to fix the heart's rhythm. Then, they implant a small device to close off a part of the heart where clots can form. The goal is to see if this …
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for liver cancer patients who have no other options
Disease control Recruiting nowThis study is testing a treatment called BSJ019T in Japanese patients with liver cancer that cannot be removed by surgery and has not responded to standard treatments. The goal is to see if the treatment can control the cancer's growth and how safe it is. About 51 participants wi…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New device targets recurrent brain tumors in early trial
Disease control Recruiting nowThis early study tests a device called TheraSphere GBM in 36 people whose glioblastoma has come back after prior treatment. The device delivers tiny radioactive beads directly to the tumor to try to control it. The main goal is to check if the procedure is safe, not yet whether i…
Phase: PHASE1 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New heart procedure could keep AFib away longer
Disease control Recruiting nowThis study tests whether adding extra scar lines in the heart, along with the standard vein isolation procedure, helps people with persistent atrial fibrillation stay in normal rhythm longer. About 640 adults aged 18–80 with symptomatic, drug-resistant persistent AFib will be ran…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Sponge treatment may fix dangerous gut leaks without more surgery
Disease control Recruiting nowThis study tests a sponge device called Endo-SPONGE to treat leaks that can happen after colorectal surgery. The sponge is placed into the leak cavity and uses suction to drain fluid and help the leak close. Researchers will check if the sponge is safe and effective in 66 adults,…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Massive new registry tracks Drug-Coated devices in real patients
Disease control Recruiting nowThis study is collecting information from 5,000 people with peripheral vascular disease who are being treated with Boston Scientific drug-eluting devices in everyday medical practice. The goal is to see how well these devices work and how safe they are in a wide range of patients…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain pacemaker tested for dystonia relief
Disease control Recruiting nowThis study is tracking how well the VERCISE™ deep brain stimulation (DBS) system works for people with dystonia, a movement disorder causing muscle spasms. Researchers will follow 300 participants aged 7 and older who are already receiving DBS to see if their symptoms improve. Th…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Brain pacemaker registry tracks Real-Life results for Parkinson's patients
Disease control Recruiting nowThis registry is collecting information from 1,500 people with Parkinson's disease who are receiving deep brain stimulation (DBS) with the Vercise system. The goal is to see how DBS affects quality of life in everyday practice, and to evaluate new programming tools. Participants …
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Brain pacemaker study aims to shake up essential tremor treatment
Disease control Recruiting nowThis study is collecting information from 500 people with essential tremor who are using a Boston Scientific deep brain stimulation (DBS) system, which is already approved for use. The goal is to see how the device affects quality of life in real-world settings, not just in contr…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Real-World check: do popular kidney stone & BPH devices hold up?
Disease control Recruiting nowThis study is tracking 238 adults who are already scheduled to have a procedure for kidney stones or an enlarged prostate (BPH) using Boston Scientific devices. The main goal is to see how often serious side effects happen with these tools in real-world use. Researchers will also…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for weight regain after gastric bypass: TORe procedure tested
Disease control Recruiting nowThis study tests a procedure called transoral outlet reduction (TORe) combined with intensive lifestyle changes for people who have regained weight after gastric bypass surgery. About 108 participants will be randomly assigned to either receive the TORe procedure plus lifestyle c…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Pain device study tracks Real-World results for thousands
Disease control Recruiting nowThis study follows 4800 adults who use a Boston Scientific neurostimulation device for pain. It aims to see how well the device works in everyday life, including pain relief and quality of life. Participants are already scheduled to try the device as part of their normal care.
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New heart pacing method tested against standard therapy in 850 patients
Disease control Recruiting nowThis study compares a newer pacing method (Left Bundle Branch Area Pacing) with the standard cardiac resynchronization therapy for people with heart failure. About 850 adults with moderate to severe heart failure will take part. The goal is to see if the newer method reduces deat…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New pacemaker lead aims to keep Heart's natural rhythm
Disease control Recruiting nowThis study is testing a pacemaker lead placed in a specific area of the heart called the left bundle branch area. The goal is to see if this placement is safe and helps the heart beat more naturally in people with slow heart rates. About 140 participants will get the lead and be …
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a balloon replace stents for clogged heart arteries?
Disease control Recruiting nowThis study tests whether a drug-coated balloon can be a safe and effective alternative to stents for treating new blockages in heart arteries. About 1,616 people will be randomly assigned to receive either the balloon or standard stent treatment. The goal is to see if the balloon…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New spine procedure tracked in 1,500 patients for back pain relief
Symptom relief Recruiting nowThis study is following 1,500 people with chronic low back pain caused by a condition called vertebrogenic pain syndrome. All participants will receive the Intracept procedure, which uses radiofrequency energy to ablate (disable) certain nerves in the spine thought to cause pain.…
Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New stimulation pattern could ease tough back pain
Symptom relief Recruiting nowThis study is testing a new way to use an already-approved spinal cord stimulator to treat chronic, hard-to-manage back and leg pain. The device sends mild electrical pulses to the spine, and the new setting (called TVP-SCS) varies the timing of those pulses. Researchers will enr…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New software could sharpen heart mapping
Knowledge-focused Recruiting nowThis study involves 100 adults with heart rhythm problems who are already scheduled for a standard heart mapping procedure. Researchers will test new software features on the mapping system to see how well they work. The goal is to gather feedback to improve future versions of th…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Jul 01, 2026 22:00 UTC
-
12,500 patients enrolled in massive heart device safety check
Knowledge-focused Recruiting nowThis registry is a large-scale effort to monitor the safety and performance of Boston Scientific cardiac devices, including pacemakers and ablation tools, in 12,500 patients. It collects data from routine procedures and follow-ups to see how well the devices work and if any compl…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
5-Year check: does this stomach procedure keep weight off?
Knowledge-focused Recruiting nowThis study looks at people who had an endoscopic sleeve gastroplasty (ESG) at least 5 years ago to see if they kept the weight off. Researchers will measure total body weight loss at the 5-year mark. The goal is to understand the long-term success of this weight-loss procedure.
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Wearable device could warn you before you faint
Knowledge-focused Recruiting nowThis study tests whether a wearable Holter monitor can detect early signs of fainting in people with orthostatic hypotension or reflex syncope. Forty adults who have already had a tilt-table test will wear the monitor for up to 21 days. The goal is to see if the device can pick u…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New mask study aims to improve how we measure breathing
Knowledge-focused Recruiting nowThis study is testing a wearable mask that measures breathing by tracking carbon dioxide in exhaled air and lung capacity. About 50 healthy adult volunteers will wear the mask at rest and during exercise. The goal is to compare two ways of measuring breathing rate to see which wo…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
5,000 patient records to reveal Real-World impact of brain stimulation
Knowledge-focused Recruiting nowThis study reviews the medical records of up to 5,000 people who have received deep brain stimulation (DBS) for Parkinson's disease, essential tremor, or dystonia. Researchers want to see how well DBS improves symptoms over time in real-world settings. No new treatments are given…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
15,000 patient records to reveal which chronic pain treatments really work
Knowledge-focused Recruiting nowThis study will look at the medical records of 15,000 people with chronic pain to see how well different treatments, like spinal cord stimulation, worked for them. The goal is to learn which approaches provide the best pain relief. No new treatments are being tested; instead, res…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Heat therapy for tremors: new study tracks Real-World results
Knowledge-focused Recruiting nowThis study is collecting information from 200 people with Parkinson's disease, dystonia, essential tremor, or other movement disorders who are scheduled to receive radiofrequency (RF) ablation—a procedure that uses heat to target small areas in the brain. The goal is to see how p…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC